Dr Joe Whittington, who goes by Dr Joe on his social media platforms is a certified MD in Emergency Medicine based in Apple Valley, California is a social media medical educator. He uploads many real-life health-related stories and cases to educate general public about it. In one such videos, he featured a woman who just had her baby four days ago and found out that she was four months pregnant.

Is This Possible?

Dr Joe says, "technically, yes". This phenomenon is known as superfetation that occurs when a woman releases an egg and it gets fertilized and implanted after she is already pregnant.

He says, "Usually pregnancy changes such as hormonal changes, changes in the uterus, and the cervical mucous plug all work to prevent this. So superfetation is extremely rare with only about 10 documented cases. But, it is possible."

What Is Superfetation?

It is a rare phenomenon where a second pregnancy occurs alongside an existing one. This happens when another ovum or the egg is fertilized by sperm and implanted in the womb days or weeks later than the first one. Babies born from superfetation are often considered twins as they may be born on the same birth on the same day. However, not always does it happen. In the case that Dr Joe picked up, the baby had a difference of four months.

ALSO READ: Pregnancy Trimesters, Everything You Need To Know About It

So, How Does It Happen?

In humans, pregnancy occurs when an egg is fertilized by sperm and implants in the uterus. For superfetation to happen, a second egg must be fertilized and implanted separately while a pregnancy is already underway.

For this to occur, three highly unlikely events must take place:

Ovulation during an ongoing pregnancy – This is rare because pregnancy hormones typically prevent further ovulation.

Fertilization of the second egg – Once pregnant, a woman’s cervix forms a mucus plug that blocks sperm from entering, making fertilization extremely unlikely.

Implantation in an already pregnant uterus – Implantation requires specific hormonal changes that usually don’t occur once pregnancy has begun.

Additionally, a growing fetus takes up space, making it harder for another embryo to implant.

Because these conditions are so improbable, superfetation is considered nearly impossible in natural pregnancies. However, a few reported cases exist, primarily in women undergoing fertility treatments like in vitro fertilization (IVF). In such cases, an embryo is transferred into the uterus, but if ovulation unexpectedly occurs and the egg is fertilized, superfetation might happen a few weeks later.

Could There Be Any Complications?

The biggest complication with superfetation is premature birth. The baby maybe born before time and could have the following medical conditions:

• trouble breathing
• low birth weight
• movement and coordination problems
• difficulties with feeding
• brain hemorrhage or bleeding in the brain
• neonatal respiratory distress syndrome, which is a breathing disorder caused by underdeveloped lungs

Women too could have complication, which includes high blood pressure and protein in the urine, a condition called preeclampsia, and gestational diabetes.

World Thalassemia Day is observed every year on May 8 to raise awareness about the inherited blood disorder caused by faulty genes.

The day was initiated in 1994 by the Thalassaemia International Federation in memory of George Englezos, the son of the federation’s founder, who succumbed to the disease.

This year’s theme, “Together for Better Care and Equal Access,” highlights the need for universal screening, safe blood availability, and advanced therapies.

The disorder, which often requires blood transfusions every fortnight, affects approximately 1.3 million people living with severe forms of thalassemia worldwide. About 1.5 percent of the global population is carriers, and the disease claims nearly 11,000 lives annually.

More than 40,000 infants are born each year with severe thalassemia, predominantly in low- and middle-income countries. Although mortality rates have declined, they remain high in developing regions, particularly in Southeast Asia.

What Is Thalassemia?

Thalassemia is an inherited hemoglobin disorder caused by defective synthesis of alpha or beta globin chains.

In β-thalassemia major, reduced or absent beta-chain production leads to ineffective erythropoiesis, severe anemia, bone marrow expansion, splenomegaly, growth retardation, and iron overload due to repeated blood transfusions.

Patients often present in early childhood with pallor, jaundice, recurrent infections, and characteristic facial bone deformities.

Thalassemia Screening

With 10,000–15,000 babies born with Thalassemia Major every single year in India, the country remains one of the global hotspots for the blood transfusion-dependent disease.

HealthandMe spoke to doctors who emphasized that carrier screening, premarital counseling, and antenatal diagnosis remain crucial preventive strategies in India, often referred to as the “thalassemia capital of the world”, as nearly one in every eight thalassemia patients globally lives in the country.

Experts stressed that normalizing conversations around screening is key to reducing the disease burden.

Dr. Ajay Sharma, Director and Head of Hematology and Hemat-Oncology at Paras Health Panchkula, said thalassemia is a preventable genetic disorder, but continues to go undetected until it is too late.

This is because “thalassemia screening, which is one of the simplest yet most overlooked preventive steps in India,” said Dr. Vishnu Hari, Associate Director and Head of Haematology & BMT at Sarvodaya Hospital, Faridabad.

“Every couple, especially those planning marriage or pregnancy, should undergo basic carrier screening. The challenge is not the availability of tests, but the lack of awareness and social hesitation around genetic conditions,” Dr. Hari said.

Also read: Reused Syringes Infect Over 330 Children in Pakistan With HIV: Report

When To Get Screened?

Screening should ideally be done early, as early detection helps informed decision-making and prevents severe health complications in children. Experts recommend screening:

• At the premarital stage
• At the start of pregnancy

What Will the Screening Find?

Carrier detection is possible with a complete blood count and a test called High Performance Liquid Chromatography (HPLC). Indicators include:

• Low haemoglobin (~9 g/dL)
• Low MCV (Mean Corpuscular Volume, ~65)
• HbA2 levels above 3.5%

“If both partners are carriers, timely genetic counselling during the antenatal phase becomes critical,” he said.

While cultural stigma and low prioritization of preventive healthcare often delay this step, the integration of routine thalassemia screening into premarital check-ups and early pregnancy care can help significantly reduce the number of affected births in India.

What Could Be Done To Manage Thalassemia?

Dr Parveen Yograj, a General Surgeon from Jammu, in a post on the social media platform X, shared that treatment for thalassemia has evolved remarkably over recent decades.

“Regular blood transfusions combined with iron chelation therapy using agents like Deferasirox and Deferiprone have significantly improved survival. Curative therapy through bone marrow transplantation is now increasingly successful, especially in children with matched donors.

"Recent breakthroughs in gene therapy and CRISPR-based genome editing offer new hope for a long-term cure by correcting defective globin gene expression,” he said.

Public health officials in South Wales, UK, have issued an alert on a localized outbreak of hepatitis A, and have urged residents to maintain hygiene as well as vaccinate children.

Cases of hepatitis A involving the same strain have been identified in three separate households in Barry, according to Public Health Wales.

The health body, in a statement, said the strain’s characteristics “suggest the infection may be spreading locally.” Investigations into the “small number” of cases are ongoing.

To curb the outbreak, the officials have also issued an urgent appeal to parents to ensure their children remain “vigilant with their handwashing.”

Those infected are “receiving appropriate care and are recovering well,” Public Health Wales said. As a precaution, close contacts of the affected individuals have also been offered vaccination.

What Is Hepatitis A?

Hepatitis A is a viral liver infection caused by the hepatitis A virus (HAV). It spreads mainly through contaminated food or water, or through close personal contact with an infected person.

The infection can lead to liver inflammation, jaundice, extreme fatigue, and stomach pain. In most cases, it is a short-term illness that clears on its own without specific treatment, although severe cases can occur. Unlike hepatitis B or C, hepatitis A does not usually cause long-term liver damage.

According to the World Health Organization (WHO), vaccination remains the most effective way to prevent infection.

Also read: Hepatitis Infections Claims 1.3 Million Lives Worldwide, India Among Top Contributors: WHO

Symptoms of Hepatitis A

Symptoms usually appear a few weeks after exposure to the virus, although some people may not develop noticeable signs. According to the Cleveland Clinic, symptoms can include:

• Persistent fatigue and weakness
• Sudden nausea, vomiting, or diarrhea
• Pain or discomfort in the upper right side of the abdomen near the liver
• Pale or clay-colored stools
• Reduced appetite
• Mild fever
• Dark-colored urine
• Joint pain
• Yellowing of the skin and eyes (jaundice)
• Severe itching

Can Hepatitis A Be Prevented?

Read More: UK Parliament Bans Smoking For People Born After 2008: Know All About It

“The best way to prevent the spread of hepatitis A is to wash hands thoroughly with soap and water. This is important after using the toilet, changing nappies, and before preparing or eating food,” said Susan Mably, Consultant in Health Protection for Public Health Wales.

Vaccination against hepatitis A is also highly effective in preventing the disease.

Doctors recommend the vaccine for:

• Children older than 12 months
• Adults at risk of exposure at home or work
• Travelers visiting regions where the virus is more common
• People with existing liver conditions

• drinking boiled or bottled water,
• avoiding food from unhygienic sources,
• peeling fruits at home and not getting pre-cut from stores.

If someone in the household is infected, cleanliness becomes even more important. Surfaces should be disinfected, food prepared carefully, and personal items not shared.

Safe sexual practices also matter, as the virus can spread through oral-anal contact. On a broader level, preventing future outbreaks requires more than short-term fixes. Improving water quality, repairing sewage systems, and strengthening public health surveillance are essential to stop the cycle from repeating.

The rates of resistance to recommended antibiotics are rising among newborns in the US, according to an analysis of invasive Escherichia coli samples.

E coli is a major neonatal pathogen in the United States and a leading cause of sepsis and mortality in newborns.

“Mortality due to E. coli sepsis remains high, especially in preterm newborns. Resistance to beta-lactams and aminoglycosides, the most common empiric treatments for E. coli sepsis, is worsening,” said researchers from the University of Missouri.

They called for tailoring treatment regimens against neonatal E. coli sepsis according to evolving antibiotic resistance trends.

“Neonatal sepsis isolates are characterized by specific genomic traits indicative of virulent phenotypes that need continued surveillance,” they added in the research published in the Open Forum Infectious Diseases journal.

What Are the Key Findings?

The researchers identified and analyzed E coli isolated from blood cultures of newborns at the hospital from 2006 to 2021. They intended to investigate the clinical characteristics of newborns with E coli bacteremia (bacteria in the blood), and the pattern of antibiotic resistance in E coli isolates over time.

“This knowledge is crucial to develop effective preventative and treatment strategies for this devastating disease,” the researchers wrote.

Of the 54 newborns identified with E coli bacteremia

• 7 developed early-onset sepsis (within 72 hours of birth or less),
• 12 were treated for E coli meningitis,
• 2 had necrotizing enterocolitis.
• Five of the newborns died, including three who were born preterm.

Antibiotic susceptibility analysis found 54 per cent of E coli isolates overall were non-susceptible to ampicillin and 11 per cent were non-susceptible to gentamicin—the two antibiotics recommended for first-line treatment in newborns with sepsis.

Also read: US CDC Links Recent Salmonella Outbreak To Backyard Poultry

Meanwhile, nonsusceptibility to ampicillin rose from 46 per cent to 61 per cent between 2006-2013 and 2014-2021.

The percentage of isolates that were non-susceptible to cefazolin, an alternative therapy, rose from 8 per cent to 36 per cent.

Whole genome sequencing revealed that the most prominent E coli sequence types (STs) were

• ST95 (17 per cent),
• ST69 (11 per cent),
• ST131 (7 per cent),
• 43 per cent of isolates contained the K1 capsule, which plays a crucial role in disease progression.

“Understanding genomic traits and molecular epidemiology trends of neonatal E. coli invasive strains is also crucial to develop novel preventative and treatment strategies that are urgently needed,” they wrote.

What Is Antibiotic Resistance?

Read More: Australia Reports Diphtheria Outbreak In Almost 50 Years: What You Need to Know

According to the National Foundation for Infectious Diseases, antibiotic resistance happens when bacteria learn to withstand the medicines(antibiotics) that are supposed to kill them. It's like the bacteria have developed a suit of armor against the drug.

When this happens, doctors have to switch to different antibiotics. These backup medicines might not work as well or might cause more side effects. Sometimes, a bacteria can become resistant to all available drugs, which leaves the patient with a dangerous infection that doctors have no way to treat. The alarming thing is that these tough, drug-resistant bacteria can spread from one person to another, both in hospitals and at home.

A 2025 report from the World Health Organization (WHO) stated that one out of every six serious infections confirmed in labs worldwide in 2024 could not be killed by the antibiotics meant to treat them.

The report noted that the standard, first-choice antibiotic is failing against over 40 per cent of E. coli.